The Eating Disorder Drug market is a subset of the Mental Disorders Drugs market. It includes drugs used to treat anorexia, bulimia, and binge eating disorder. These drugs are typically prescribed by psychiatrists and other mental health professionals. Commonly used drugs include selective serotonin reuptake inhibitors (SSRIs), antipsychotics, and mood stabilizers. These drugs are used to reduce symptoms such as depression, anxiety, and obsessive-compulsive behavior. The Eating Disorder Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca, and Novartis. Other companies include Allergan, Merck, and Johnson & Johnson. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
